1. Home
  2. HAYW vs RARE Comparison

HAYW vs RARE Comparison

Compare HAYW & RARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HAYW
  • RARE
  • Stock Information
  • Founded
  • HAYW 1925
  • RARE 2010
  • Country
  • HAYW United States
  • RARE United States
  • Employees
  • HAYW N/A
  • RARE N/A
  • Industry
  • HAYW Electronic Components
  • RARE Biotechnology: Pharmaceutical Preparations
  • Sector
  • HAYW Technology
  • RARE Health Care
  • Exchange
  • HAYW Nasdaq
  • RARE Nasdaq
  • Market Cap
  • HAYW 2.9B
  • RARE 3.5B
  • IPO Year
  • HAYW 2021
  • RARE 2014
  • Fundamental
  • Price
  • HAYW $14.20
  • RARE $39.91
  • Analyst Decision
  • HAYW Hold
  • RARE Strong Buy
  • Analyst Count
  • HAYW 5
  • RARE 15
  • Target Price
  • HAYW $16.83
  • RARE $90.53
  • AVG Volume (30 Days)
  • HAYW 1.8M
  • RARE 1.1M
  • Earning Date
  • HAYW 07-29-2025
  • RARE 07-31-2025
  • Dividend Yield
  • HAYW N/A
  • RARE N/A
  • EPS Growth
  • HAYW 51.32
  • RARE N/A
  • EPS
  • HAYW 0.56
  • RARE N/A
  • Revenue
  • HAYW $1,067,878,000.00
  • RARE $590,689,000.00
  • Revenue This Year
  • HAYW $5.27
  • RARE $18.94
  • Revenue Next Year
  • HAYW $5.51
  • RARE $28.93
  • P/E Ratio
  • HAYW $25.37
  • RARE N/A
  • Revenue Growth
  • HAYW 7.34
  • RARE 33.46
  • 52 Week Low
  • HAYW $11.10
  • RARE $29.59
  • 52 Week High
  • HAYW $16.87
  • RARE $60.37
  • Technical
  • Relative Strength Index (RSI)
  • HAYW 56.89
  • RARE 65.02
  • Support Level
  • HAYW $13.63
  • RARE $35.51
  • Resistance Level
  • HAYW $14.58
  • RARE $38.19
  • Average True Range (ATR)
  • HAYW 0.37
  • RARE 1.58
  • MACD
  • HAYW 0.05
  • RARE 0.20
  • Stochastic Oscillator
  • HAYW 72.73
  • RARE 98.43

About HAYW Hayward Holdings Inc.

Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2024.

About RARE Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.

Share on Social Networks: